Results 181 to 190 of about 50,080 (291)

Misoprostol for postpartum hemorrhage: Moving from evidence to practice

, 2011
Ann Starrs, Beverly Winikoff
openalex   +1 more source

Clinical Effectiveness and Cost-Effectiveness of Misoprostol in Comparison to Dilatation and Curettage for Treatment of First-Trimester Missed Abortion (Gestational Age ≤ 14 Weeks) in Iran. [PDF]

Health Sci Rep
Husseini Barghazan S, Hadian M, Rezapour A, Nassiri S, Meshkani Z, Norouzi S.   +5 more
europepmc   +1 more source

Misoprostol combined with artificial membrane stripping showed the best effect of induction among women with gestational diabetes mellitus: a retrospective cohort study. [PDF]

Rev Assoc Med Bras (1992)
Li X, Yang Q, Zhang X, He L, Wu J.
europepmc   +1 more source

The Impact of Maternal BMI on the Efficacy and Safety of Oral Misoprostol for Labor Induction. [PDF]

Pharmaceuticals (Basel)
Socha MW, Flis W, Sowińska J, Stankiewicz M, Kazdepka-Ziemińska A.   +4 more
europepmc   +1 more source

Oral misoprostol is an effective and acceptable alternative to vaginal administration for cervical priming before first trimester pregnancy termination

, 2012
Madhusudan Dey
openalex   +2 more sources

Misoprostol inhibits gastric mucosal release of endogenous prostaglandin E2 and thromboxane B2 in healthy volunteers. [PDF]

, 1995
Nielsen Am, Ole Eskerod, Klaus Bukhave, J Rask-Madsen   +3 more
openalex   +1 more source

Paeniclostridium sordelli toxic shock syndrome after a septic abortion - A case report. [PDF]

IDCases
Kambam G, Crusio R.
europepmc   +1 more source

Mifepristone and misoprostol versus misoprostol alone for induction of labor in women with intrauterine fetal death: A meta‐analysis and systematic review [PDF]

Paloma Oliveira, Artur Menegaz de Almeida, Mauro André Azevedo Silva Kaiser Cabral, Gustavo Lima Guilherme, Ana Filipa D Castilho M Ribeiro, João Antônio Zanette Giusti, Rafael Morais Esteves de Lima, Jéssica Cristine da Silva Garcia, Ricardo de Oliveira   +8 more
openalex   +1 more source

Low-dose oral misoprostol vs. oxytocin in premature rupture of membranes at ≥ 36 weeks: a comparison of labor induction outcomes and postpartum hemorrhage risk. [PDF]

BMC Pregnancy Childbirth
Yang Y, Yu Z, Shi H, Wang Y, Zhao Y.
europepmc   +1 more source

Closing the Gap: Expanding Access to Mifepristone for Early Pregnancy Loss Through Operational Innovation. [PDF]

J Am Coll Emerg Physicians Open
Rowh MAW, Hellmann R, Varshney J, Kass D.   +3 more
europepmc   +1 more source